Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_assertion type Assertion NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_head.
- NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_assertion description "[We recently reported induction of UGT2B7 by its substrate epirubicin, a cytotoxic anthracycline anticancer drug, via activation of p53 and subsequent recruitment of p53 to the UGT2B7 promoter in hepatocellular carcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_provenance.
- NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_assertion evidence source_evidence_literature NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_provenance.
- NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_assertion SIO_000772 25713207 NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_provenance.
- NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_assertion wasDerivedFrom befree-2016 NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_provenance.
- NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_assertion wasGeneratedBy ECO_0000203 NP1266175.RAp3WasoDLpY2sIhWctyCzBW_e5sMjxxeW7xsLkNlibEo130_provenance.